Koch G L, Smith M J
Br J Cancer. 1983 Apr;47(4):527-36. doi: 10.1038/bjc.1983.83.
The Con A acceptor glycoproteins of murine and human tumour cell lines revealed by two-dimensional fingerprinting on polyacrylamide gels fall into two main categories: constant glycoproteins expressed by all cell lines and variable glycoproteins which are only expressed by particular tumour cell lines. Since the number of variable glycoproteins on a typical fingerprint is 50, fingerprints from different cell lines are readily distinguishable. However the variable glycoproteins are not expressed idiosyncratically and cell lines derived from similar classes of tumours express similar patterns of the variable glycoproteins. For example, murine fibrosarcomas express patterns which are virtually identical with one another. Characteristic patterns are also expressed by murine macrophage tumour lines, human carcinomas and human B lymphoblastoid cells. Thus, the variable glycoproteins behave as a set of linked markers which are indicators of the type of normal pre-neoplastic precursor cell from which a tumour is derived and appear to be a new type of marker for tumour cell classification. Antibodies to these glycoproteins could prove useful in tumour localisation and diagnosis.
通过聚丙烯酰胺凝胶二维指纹图谱揭示的小鼠和人类肿瘤细胞系的刀豆球蛋白A受体糖蛋白可分为两大类:所有细胞系均表达的恒定糖蛋白和仅由特定肿瘤细胞系表达的可变糖蛋白。由于典型指纹图谱上可变糖蛋白的数量为50种,不同细胞系的指纹图谱很容易区分。然而,可变糖蛋白并非特异性表达,源自相似肿瘤类别的细胞系表达相似的可变糖蛋白模式。例如,小鼠纤维肉瘤表达的模式几乎彼此相同。小鼠巨噬细胞瘤系、人类癌和人类B淋巴母细胞也表达特征性模式。因此,可变糖蛋白表现为一组连锁标记,它们是肿瘤起源的正常肿瘤前体细胞类型的指标,似乎是一种新型的肿瘤细胞分类标记。针对这些糖蛋白的抗体可能在肿瘤定位和诊断中有用。